Source: FAA Blog

FAA Blog FAA Research Institute Contributes to Global Study on Mepolizumab's Effectiveness in Severe Asthma

The post FAA Research Institute Contributes to Global Study on Mepolizumab's Effectiveness in Severe Asthma appeared first on Family Allergy & Asthma.

Read full article »

FAA's Competitors | FAA's News | FAA's Financials

Followers on Owler

177

Est. Annual Revenue

$100-500M

Est. Employees

500-1.0K

CEO

Greg Meadows

CEO Approval Rating

83/100

Family Allergy & Asthma is a Kentucky-based healthcare organization that owns and operates a chain of hospitals offering treatment in areas such as allergies and asthma.